Studies have demonstrated that certain kallikreins, notably, KLK5, KLK6, and KLK10, can be identified in the ascitic fluid of patients with ovarian cancer, with average concentrations measured at 62.2 ng/mL, 144 ng/mL, and 57 ng/mL, respectively [35]. This evidence concerns the gene KLK4 and ovarian carcinoma.